Cited by 1,518Neuroscience and Neuropharmacology ResearchAmino Acid Enzymes and MetabolismNeuroprotection in Cerebral Ischemia

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

Rothstein, Jeffrey D., Patel, Sarjubhai, Regan, Melissa R., Haenggeli, Christine, Huang, Yanhua H., Bergles, Dwight E., Jin, Lin, Dykes Hoberg, Margaret, Vidensky, Svetlana, Chung, Dorothy S., Toan, Shuy Vang, Bruijn, Lucie I., Su, Zao-zhong, Gupta, Pankaj, Fisher, Paul B.·2005·Nature

DOI 10.1038/nature03180

Open this paper in CoChat — free account

Abstract

Glutamate is the principal excitatory neurotransmitter in the nervous system. Inactivation of synaptic glutamate is handled by the glutamate transporter GLT1 (also known as EAAT2; refs 1, 2), the physiologically dominant astroglial protein. In spite of its critical importance in normal and abnormal synaptic activity, no practical pharmaceutical can positively modulate this protein. Animal studies show that the protein is important for normal excitatory synaptic transmission, while its dysfunction is implicated in acute and chronic neurological disorders, including amyotrophic lateral sclerosis (ALS), stroke, brain tumours and epilepsy. Using a blinded screen of 1,040 FDA-approved drugs and nutritionals, we discovered that many beta-lactam antibiotics are potent stimulators of GLT1 expression. Furthermore, this action appears to be mediated through increased transcription of the GLT1 gene. beta-Lactams and various semi-synthetic derivatives are potent antibiotics that act to inhibit bacterial synthetic pathways. When delivered to animals, the beta-lactam ceftriaxone increased both brain expression of GLT1 and its biochemical and functional activity. Glutamate transporters are important in preventing glutamate neurotoxicity. Ceftriaxone was neuroprotective in vitro when used in models of ischaemic injury and motor neuron degeneration, both based in part on glutamate toxicity. When used in an animal model of the fatal disease ALS, the drug delayed loss of neurons and muscle strength, and increased mouse survival. Thus these studies provide a class of potential neurotherapeutics that act to modulate the expression of glutamate neurotransmitter transporters via gene activation.

Integrity signals

Registry

Crossref · 10.1038/nature03180

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,796
Glutamate uptake
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Self-citation
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., et al. (1997) · Science · doi:10.1126/science.276.5319.1699 · Cited by 1,755
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis
Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471
Self-citation
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
Rothstein, J. D., Martin, L. J., & Kuncl, R. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262204 · Cited by 1,197
Self-citation
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)
Howland, D., Liu, J., She, Y., Goad, B., Maragakis, N. J., Kim, B. B., Erickson, J., Kulik, J., DeVito, L., Psaltis, G. C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032539299 · Cited by 890
Self-citation
Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model
Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003) · Science · doi:10.1126/science.1086137 · Cited by 872
Self-citation
Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.
Rothstein, J. D., Jin, L., Dykes‐Hoberg, M., & Kuncl, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6591 · Cited by 623
Self-citation

Flagged first, then by citations

Show all 27 references

Sorted by citations

Items 801–900 of 1,000

Solid-phase based synthesis of biologically promising triazolyl aminoacyl (peptidyl) penicillins
Cornier, P. G., Boggián, D. B., Mata, E. G., & Delpiccolo, C. M. L. (2011) · Tetrahedron Letters · doi:10.1016/j.tetlet.2011.11.113 · Cited by 24
Expression of EAAT-1 distinguishes choroid plexus tumors from normal and reactive choroid plexus epithelium
Beschorner, R., Pantazis, G., Jeibmann, A., Boy, J., Meyermann, R., Mittelbronn, M. G. A., & Schittenhelm, J. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0519-y · Cited by 24
Interleukin-1β regulation of N-type Ca2+ channels in cortical neurons
Zhou, C. Y., Ye, H., Wang, S., & Chai, Z. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.04.043 · Cited by 24
Molecular determinants of transport stimulation of EAAT 2 are located at interface between the trimerization and substrate transport domains
Mortensen, O. V., Liberato, J. L., Coutinho‐Netto, J., dos Santos, W. F., & Fontana, A. C. K. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13047 · Cited by 24
Molecular Motor Proteins and Amyotrophic Lateral Sclerosis
Soo, K. Y., Farg, M. A., & Atkin, J. D. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12129057 · Cited by 24
Antinociceptive effect of clavulanic acid and its preventive activity against development of morphine tolerance and dependence in animal models.
Hajhashemi, V., & Dehdashti, K. (2014) · Europe PMC (PubMed Central) · Cited by 24
Human nasal olfactory epithelium as a dynamic marker for CNS therapy development
Sattler, R., Ayukawa, Y., Coddington, L. T., Sawa, A., Block, D., Chipkin, R. E., & Rothstein, J. D. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.002 · Cited by 24
Self-citation
Changes in feeding, social, and lying behaviors in dairy cows with metritis following treatment with a nonsteroidal anti-inflammatory drug as adjunctive treatment to an antimicrobial
Lomb, J., Neave, H. W., Weary, D. M., LeBlanc, S. J., Huzzey, J. M., & von Keyserlingk, M. A. G. (2018) · Journal of Dairy Science · doi:10.3168/jds.2017-13812 · Cited by 24
Glial loss of the metallo β-lactamase domain containing protein, SWIP-10, induces age- and glutamate-signaling dependent, dopamine neuron degeneration
Gibson, C. L., Balbona, J. T., Niedzwiecki, A., Rodriguez, P., Nguyen, K. C. Q., Hall, D. H., & Blakely, R. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007269 · Cited by 24
Stem Cells, Regenerative Medicine, and Animal Models of Disease
Steindler, D. A. (2007) · ILAR Journal · doi:10.1093/ilar.48.4.323 · Cited by 24
Astrocyte GRK2 as a novel regulator of glutamate transport and brain damage
Nijboer, C. H. A., Heijnen, C. J., Degos, V., Willemen, H. L. D. M., Gressèns, P., & Kavelaars, A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.12.013 · Cited by 25
Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies
Bruijn, L. I., & Cudkowicz, M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.3.417 · Cited by 24
Self-citation
β-Lactam Antibiotics
Hubschwerlen, C. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00218-2 · Cited by 24
Antibiotics rescue neurons from glutamate attack
Tanaka, K. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.04.002 · Cited by 24
Zn2+ Modulation of Neurotransmitter Transporters
Norgaard-Nielsen, K., & Gether, U. (2006) · Springer eBooks · doi:10.1007/3-540-29784-7_1 · Cited by 25
Lack of Effect of Ceftriaxone, a GLT-1 Transporter Activator, on Spatial Memory in Mice
Karaman, I., Kizilay-Ozfidan, G., Karadag, C. H., & Ulugol, A. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.04.013 · Cited by 23
The role of macrophage plasticity in neurodegenerative diseases
Ma, H., Zhu, M., Chen, M., Li, X., & Feng, X. (2024) · Biomarker Research · doi:10.1186/s40364-024-00624-7 · Cited by 24
Expeditious Entry to Enantiopure Mono‐ and Bis(Tricyclic) β‐Lactams by Single or Double [2+2] Cycloaddition of Allenynes
Alcaide, B., Almendros, P., Aragoncillo, C., & Gómez‐Campillos, G. (2010) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201001233 · Cited by 23
Effects of neural stem cell transplantation on the motor function of rats with contusion spinal cord injuries: a meta-analysis
Li, L., Wang, Z., Qian, K., Xu, T., Wang, X., Ma, T., Zhang, K., YANG, K. Y., Qian, T., & Shi, J. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266915 · Cited by 24
Research Progress of Microbiota-Gut-Brain Axis in Parkinson's Disease
Zhang, W., Ye, Y., Song, J., Sang, T., Xia, T., Xie, L., Qiu, X., Zeng, Q., & Luo, X. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206157 · Cited by 30
Ceftriaxone Preconditioning Confers Neuroprotection in Neonatal Rats Through Glutamate Transporter 1 Upregulation
Mimura, K., Tomimatsu, T., Minato, K., Jugder, O., Kinugasa-Taniguchi, Y., Kanagawa, T., Nozaki, M., Yanagihara, I., & Kimura, T. (2011) · Reproductive Sciences · doi:10.1177/1933719111410710 · Cited by 23
Pharmacological induction of ischemic tolerance in hippocampal slices by sarcosine preconditioning
Pinto, M. C. X., Mourão, F. A. G., Binda, N. S., Leite, H. R., Gomez, M. V., Massensini, A. R., & Gomez, R. S. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.06.018 · Cited by 23
Therapeutic Strategies For The Treatment Of Spinal Muscular Atrophy
Cherry, J. J., & Androphy, E. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.107 · Cited by 23
Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice
Tallarida, C. S., Corley, G., Kovalevich, J., Yen, W., Langford, D., & Rawls, S. M. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.072 · Cited by 23
Localized infusions of the partial alpha 7 nicotinic receptor agonist SSR180711 evoke rapid and transient increases in prefrontal glutamate release
Bortz, D. M., Mikkelsen, J. D., & Bruno, J. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.047 · Cited by 23
Neuroprotective effect of ceftriaxone on the penumbra in a rat venous ischemia model
Inui, T., Alessandri, B., Heimann, A., Nishimura, F., Frauenknecht, K. B. M., Sommer, C., & Kempski, O. S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.018 · Cited by 23
Lansoprazole Upregulates Polyubiquitination of the TNF Receptor-Associated Factor 6 and Facilitates Runx2-mediated Osteoblastogenesis
Mishima, K., Kitoh, H., Ohkawara, B., Okuno, T., Ito, M., Masuda, A., Ishiguro, N., & Ohno, K. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.024 · Cited by 23
The nature of early astroglial protection—Fast activation and signaling
Kardos, J., Héja, L., Jemnitz, K., Kovács, R., & Palkovits, M. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.005 · Cited by 23
Can a Selective Serotonin Reuptake Inhibitor Act as a Glutamatergic Modulator?
Frizzo, M. E. (2017) · Current Therapeutic Research · doi:10.1016/j.curtheres.2017.07.001 · Cited by 25
Effect of ceftriaxone on paired-pulse response and long-term potentiation of hippocampal dentate gyrus neurons in rats with Alzheimer-like disease
Hamidi, N., Nozad, A., Milan, H. S., Salari, A., & Amani, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116969 · Cited by 23
Targeting an Old Mechanism in a New Disease—Protection of Glutamatergic Dysfunction in Depression
Sattler, R., & Rothstein, J. D. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.011 · Cited by 24
Self-citation
The rise of astrocytes: are they guardians or troublemakers of the brain disorder?
Kim, H. Y., Kim, S., Akaydin, A. N., Kim, S. S., Hyeon, S. J., Lee, J.-H., & Ryu, H. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01627-6 · Cited by 28
Drug repurposing – A search for novel therapy for the treatment of diabetic neuropathy
Paul, A., Kumar, M., Das, P., Guha, N., Rudrapal, M., & Zaman, K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113846 · Cited by 22
The mGluR2/3 Agonist LY379268 Blocks the Effects of GLT-1 Upregulation on Prepulse Inhibition of the Startle Reflex in Adult Rats
Bellesi, M., & Conti, F. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.225 · Cited by 22
Reduction of EEG Theta Power and Changes in Motor Activity in Rats Treated with Ceftriaxone
Bellesi, M., Vyazovskiy, V. V., Tononi, G., Cirelli, C., & Conti, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034139 · Cited by 22
Gold as Catalyst for the Hydroarylation and Domino Hydroarylation/N1–C4 Cleavage of β-Lactam-Tethered Allenyl Indoles
Alcaide, B., Almendros, P., Cembellín, S., & del Campo, T. M. (2015) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b00535 · Cited by 22
Effects of cefazolin and cefoperazone on glutamate transporter 1 isoforms and cystine/glutamate exchanger as well as alcohol drinking behavior in male alcohol-preferring rats
Alasmari, F. F., Rao, S., & Sari, Y. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.007 · Cited by 22
Designing Novel Nanoformulations Targeting Glutamate Transporter Excitatory Amino Acid Transporter 2: Implications in Treating Drug Addiction.
Rao, P., Yallapu, M. M., Sari, Y., Fisher, P. B., & Kumar, S. (2015) · PubMed · Cited by 21
Self-citation
Antibiotic drug piperacillin induces neuron cell death through mitochondrial dysfunction and oxidative damage
Jiang, S., Li, T., Zhou, X., Qin, W., Wang, Z., & Liao, Y. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0679 · Cited by 22
Nucleus accumbens GLT-1a overexpression reduces glutamate efflux during reinstatement of cocaine-seeking but is not sufficient to attenuate reinstatement
Logan, C. N., LaCrosse, A., & Knackstedt, L. A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.022 · Cited by 22
Astroglial Cx30 sustains neuronal population bursts independently of gap‐junction mediated biochemical coupling
Pannasch, U., Dossi, E., Ezan, P., & Rouach, N. (2019) · Glia · doi:10.1002/glia.23591 · Cited by 23
Ceftriaxone regulates glutamate production and vesicular assembly in presynaptic terminals through GLT-1 in APP/PS1 mice
Fan, S., Li, L., Xian, X., Liu, L., Gao, J., & Li, W. (2021) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2021.107480 · Cited by 22
Gold-catalyzed bis-cyclization of 1,2-diol- or acetonide-tethered alkynes. Synthesis of ?-lactam-bridged acetals: a combined experimental and theoretical study
Alcaide, B., Almendros, P., Carrascosa, R., L�pez, R., & Menndez, M. I. (2012) · Tetrahedron · doi:10.1016/j.tet.2012.03.028 · Cited by 22
Alterations in Neuronal Survival and Glial Reactions after Axotomy by Ceftriaxone and Minocycline in the Mouse Hypoglossal Nucleus
Yamada, J., & Jinno, S. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.051 · Cited by 21
EAAT2 Activation Regulates Glutamate Excitotoxicity and Reduces Impulsivity in a Rodent Model of Parkinson’s Disease
Das, S., Mccloskey, K., Nepal, B., & Kortagere, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04644-0 · Cited by 22
Perspectives on “Chronic Lyme Disease”
Baker, P. J. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.02.013 · Cited by 21
Ampicillin/Sulbactam Treatment Modulates NMDA Receptor NR2B Subunit and Attenuates Neuroinflammation and Alcohol Intake in Male High Alcohol Drinking Rats
Alasmari, F. F., Alhaddad, H., Wong, W., Bell, R. L., & Sari, Y. (2020) · Biomolecules · doi:10.3390/biom10071030 · Cited by 21
GLT-1 Knockdown Inhibits Ceftriaxone-Mediated Improvements on Cognitive Deficits, and GLT-1 and xCT Expression and Activity in APP/PS1 AD Mice
Gao, J., Liu, L., Liu, C., Fan, S., Liu, L., Liu, S., Xian, X., & Li, W. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.580772 · Cited by 21
Why should we care about astrocytes in a motor neuron disease?
Dittlau, K. S., & Bosch, L. V. D. (2023) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2023.1047540 · Cited by 24
Neuropharmacological insight into preventive intervention in posttraumatic epilepsy based on regulating glutamate homeostasis
Gao, Y., Liu, N., Chen, J., Zheng, P., Niu, J., Tang, S., Peng, X., Wu, J., Yu, J., & Ma, L. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14294 · Cited by 20
New therapeutic targets for amyotrophic lateral sclerosis
Kuźma‐Kozakiewicz, M., & Kwieciński, H. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.542152 · Cited by 22
Fluoxetine treatment induces EAAT2 expression in rat brain
Zink, M., Rapp, S., Donev, R., Gebicke‐Haerter, P. J., & Thome, J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0536-y · Cited by 24
Effectiveness of Ceftriaxone Treatment in Preventing Relapse-like Drinking Behavior Following Long-term Ethanol Dependence in P Rats
Sari, Y. (2014) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000183 · Cited by 21
Designing Clinical Trials in Amyotrophic Lateral Sclerosis
Shefner, J. M. (2008) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2008.02.002 · Cited by 21
Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism: Table 1
Auwaerter, P. G., Bakken, J., Dattwyler, R. J., Dumler, J. S., HALPERIN, J. J., McSweegan, E. F., Nadelman, R. B., O'Connell, S. M., Sood, S. K., Weinstein, A., et al. (2010) · Journal of Medical Ethics · doi:10.1136/jme.2009.032896 · Cited by 21
Neurotrophic Peptides: Potential Drugs for Treatment of Amyotrophic Lateral Sclerosis and Alzheimer’s disease
Ciesler, J., & Sari, Y. (2013) · Open Journal of Neuroscience · doi:10.13055/ojns_3_1_2.130408 · Cited by 21
P2X3 receptor‐mediated visceral hyperalgesia and neuronal sensitization following exposure to PTSD ‐like stress in the dorsal root ganglia of rats
He, Y., Lang, X.-Q., Lin, L., Ji, L., Yuan, X. ‐., Chen, Q., Ran, Y. ‐., Chen, H. ‐., Li, L., Wang, J. ‐., et al. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12976 · Cited by 21
Interventional and preventive effects of aripiprazole and ceftriaxone used alone or in combination on oxaliplatin-induced tactile and cold allodynia in mice
Sałat, K., Furgała, A., & Sałat, R. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.01.008 · Cited by 21
Ceftriaxone Treatment Affects EAAT2 Expression and Glutamatergic Neurotransmission and Exerts a Weak Anticonvulsant Effect in Young Rats
Zaitsev, A. V., Malkin, S. L., Postnikova, T. Y., Smolensky, I. V., Zubareva, O. E., Romanova, I. V., Zakharova, M. V., Karyakin, V. B., & Zavyalov, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235852 · Cited by 21
Monocyclic beta–lactams for therapeutic uses: a patent overview (2010–2020)
Grabrijan, K., Strašek, N., & Gobec, S. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1865919 · Cited by 21
Carboxymethylproline synthase catalysed syntheses of functionalised N-heterocycles
Hamed, R. B., Mecinović, J., Ducho, C., Claridge, T. D. W., & Schofield, C. J. (2010) · Chemical Communications · doi:10.1039/b924519g · Cited by 21
Drug Therapy in Amyotrophic Lateral Sclerosis
Distad, B. J., Meekins, G. D., Liou, L. L., Weiss, M. D., Carter, G. T., & Miller, R. G. (2008) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2008.04.005 · Cited by 21
Targeting protein aggregation in neurodegeneration – lessons from polyglutamine disorders
Weydt, P., & Spada, A. R. L. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.505 · Cited by 21
Excitatory amino acid transporter 2 and excitatory amino acid transporter 1 negatively regulate calcium‐dependent proliferation of hippocampal neural progenitor cells and are persistently upregulated after injury
Gilley, J. A., & Kernie, S. G. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07888.x · Cited by 20
Glutamate transporter activation enhances nicotine antinociception and attenuates nicotine analgesic tolerance
Schroeder, J. A., Quick, K. F., Landry, P. M., & Rawls, S. M. (2011) · Neuroreport · doi:10.1097/wnr.0b013e32834d87eb · Cited by 20
In vivo comparison of harmine efficacy against psychostimulants: Preferential inhibition of the cocaine response through a glutamatergic mechanism
Owaisat, S., Raffa, R. B., & Rawls, S. M. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.07.052 · Cited by 20
Pyridazine-derivatives Enhance Structural and Functional Plasticity of Tripartite Synapse Via Activation of Local Translation in Astrocytic Processes
Foster, J. B., Zhao, F., Wang, X., Xu, Z., Lin, K. J., Askwith, C. C., Hodgetts, K. J., & Lin, C. G. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.07.028 · Cited by 20
Astrocytes in Motor Neuron Diseases
Valori, C. F., Guidotti, G., Brambilla, L., & Rossi, D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_10 · Cited by 19
NCX activity generates spontaneous Ca2+ oscillations in the astrocytic leaflet microdomain
Héja, L., & Kardos, J. (2019) · Cell Calcium · doi:10.1016/j.ceca.2019.102137 · Cited by 20
Stereoselective synthesis of spiro-β-lactams using d-(+)-glucose derived chiral pool: remarkable influence of the torquoelectronic effect
Chincholkar, P. M., Puranik, V. G., & Deshmukh, A. R. A. S. (2007) · Tetrahedron · doi:10.1016/j.tet.2007.06.073 · Cited by 20
Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice
Yamamoto, R., Matsushita, M., Kitoh, H., Masuda, A., Ito, M., Katagiri, T., Kawai, T., Ishiguro, N., & Ohno, K. (2012) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0380-2 · Cited by 20
Systemic infections in multiple sclerosis and experimental autoimmune encephalomyelitis
Tauber, S. C., Nau, R., & Gerber, J. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701531227 · Cited by 20
Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application
Marzban, H., Kong, J., Mehr, S. E., Vriend, J. P., Li, J., Guan, T., Chung, S., Mirzaei, N., Marzban, A., Shojaei, S., et al. (2016) · Current Molecular Pharmacology · doi:10.2174/1874467209666160112125446 · Cited by 20
Cephalosporins
Alcaide, B., Aragoncillo, C., & Almendros, P. (2008) · Elsevier eBooks · doi:10.1016/b978-008044992-0.00202-9 · Cited by 20
Ceftriaxone has a therapeutic role in Alexander disease
Sechi, G., Balbi, P., Bachetti, T., Matta, M., Serra, A., Deiana, G. A., Zanni, E. D., & Ceccherini, I. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.11.021 · Cited by 21
Memory-enhancing treatments reverse the impairment of inhibitory avoidance retention in sepsis-surviving rats
Tuon, L., Comim, C. M., Petronilho, F. C., Barichello, T., Izquierdo, I., Quevedo, J., & Dal‐Pizzol, F. (2008) · Critical Care · doi:10.1186/cc7103 · Cited by 20
Expression and purification of the mitochondrial serine protease LACTB as an N-terminal GST fusion protein in Escherichia coli
Liobikas, J., Polianskyte-Prause, Z., Speer, O., Thompson, J. S., Alakoskela, J.-M. I., Peitsaro, N., Franck, M. C. M., Whitehead, M. A., Kinnunen, P. K. J., & Eriksson, O. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2005.08.006 · Cited by 20
Identification and Structure–Activity Relationship Study of Imidazo[1,2-a]pyridine-3-amines as First Selective Inhibitors of Excitatory Amino Acid Transporter Subtype 3 (EAAT3)
Wu, P., Bjørn-Yoshimoto, W. E., Staudt, M., Jensen, A. A., & Bunch, L. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00447 · Cited by 18
The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders
Alijanpour, S., Miryounesi, M., & Ghafouri‐Fard, S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01091-5 · Cited by 20
Pre-traumatic antibiotic-induced microbial depletion reduces neuroinflammation in acute murine traumatic brain injury
Ritter, K., Vetter, D., Wernersbach, I., Schwanz, T., Hummel, R., & Schäfer, M. K. E. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109648 · Cited by 19
ALS Untangled No. 20: The Deanna Protocol
The ALSUntangled Group (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.788405 · Cited by 19
Cerebral ischemic pre‐conditioning enhances the binding characteristics and glutamate uptake of glial glutamate transporter‐1 in hippocampal CA1 subfield of rats
Liu, A., Hu, Y., Li, W., Xu, J., & Zhang, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07396.x · Cited by 19
Antibiotics acting as neuroprotectants via mechanisms independent of their anti-infective activities
Stock, M. L., Fiedler, K. J., Acharya, S., Lange, J. K., Mlynarczyk, G. S. A., Anderson, S. J., Schmidt-McCormack, G. R., Kanuri, S. H., Kondru, N. C., Brewer, M. T., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.059 · Cited by 20
Synthesis of Novel Bis(β‐lactam)‐1,3‐diynes by Copper‐Promoted Homo‐ or Cross‐Coupling of Alkynyl‐2‐azetidinones
Alcaide, B., Almendros, P., Carrascosa, R., & Rodríguez‐Acebes, R. (2008) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200701083 · Cited by 19
Upregulation of calcium binding protein, S100A6, in activated astrocytes is linked to glutamate toxicity
Yamada, J., & Jinno, S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.068 · Cited by 19
Stereoselective cyanation of 4-formyl and 4-imino-?-lactams: application to the synthesis of polyfunctionalized ?-lactams
Alcaide, B., Almendros, P., Cabrero, G., & Ruiz, M. P. (2012) · Tetrahedron · doi:10.1016/j.tet.2012.02.062 · Cited by 19
Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus
Medrano, M., Mendiguren, A., & Pineda, J. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3913-2 · Cited by 19
Framing Neuro-Glia Coupling in Antiepileptic Drug Design
Kardos, J., Szabó, Z. M., & Héja, L. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00331 · Cited by 19
Synthesis and Biological Evaluation of Novel Neuroprotective Pyridazine Derivatives as Excitatory Amino Acid Transporter 2 (EAAT2) Activators
Chelini, A., Brogi, S., Paolino, M., Capua, A. D., Cappelli, A., Giorgi, G., Farzad, M., Mannelli, L. D. C., Micheli, L., Ghelardini, C., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00383 · Cited by 19
Intermittent hypoxia training: Powerful, non-invasive cerebroprotection against ethanol withdrawal excitotoxicity
Jung, M. E., & Mallet, R. T. (2017) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2017.08.007 · Cited by 22
An Update on Medications for Brain Arteriovenous Malformations
Raper, D. M. S., Winkler, E. A., Rutledge, C., Cooke, D. L., & Abla, A. A. (2020) · Neurosurgery · doi:10.1093/neuros/nyaa192 · Cited by 19
Cell-Autonomous Enhancement of Glutamate-Uptake by Female Astrocytes
Morizawa, Y. M., Sato, K., Takaki, J., Kawasaki, A., Shibata, K., Suzuki, T., Ohta, S., & Koizumi, S. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9829-z · Cited by 19
Role for GABA and Glu Plasma Membrane Transporters in the Interplay of Inhibitory and Excitatory Neurotransmission
Héja, L., Karacs, K., & Kardos, J. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777323656 · Cited by 19
The Role of Astrocytes and Alpha-Synuclein in Parkinson’s Disease: A Review
Brash-Arias, D., García, L. I., Pérez-Estudillo, C. A., Rojas-Durán, F., Aranda-Abreu, G. E., Herrera‐Covarrubias, D., & Chi-Castañeda, D. (2024) · NeuroSci · doi:10.3390/neurosci5010005 · Cited by 20
High-throughput drug screens for amyotrophic lateral sclerosis drug discovery
McGown, A., & Stopford, M. J. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1533953 · Cited by 17
Brain fog in long COVID: A glutamatergic hypothesis with astrocyte dysfunction accounting for brain PET glucose hypometabolism
Horowitz, T., Pellerin, L., Zimmer, E. R., & Guedj, É. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111186 · Cited by 19
Aberrant Control of Motoneuronal Excitability in Amyotrophic Lateral Sclerosis: Excitatory Glutamate / D ‐Serinevs.Inhibitory Glycine/γ‐Aminobutanoic Acid (GABA)
Sasabe, J., & Aiso, S. (2010) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900306 · Cited by 18
Effects of the excitatory amino acid transporter subtype 2 (EAAT-2) inducerceftriaxone on different pain modalities in rat
Eljaja, L., Bjerrum, O. J., Honoré, P. H., & Abrahamsen, B. (2011) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2011.03.003 · Cited by 18
Huntington’s Disease: Pathogenic Mechanisms and Therapeutic Targets
Wright, D. J., Renoir, T., Gray, L. J., & Hannan, A. J. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_4 · Cited by 17
Entering a new era of quantifying glutamate clearance in health and disease
Brymer, K. J., Barnes, J. R., & Parsons, M. P. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24810 · Cited by 17

Authors: Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., Toan, S. V., Bruijn, L. I., Su, Z.-Z., Gupta, P., & Fisher, P. B.
Affiliations: Johns Hopkins University (US)
Amyotrophic Lateral Sclerosis Association (US)
Columbia University Irving Medical Center (US)
Corresponding author: Rothstein, Jeffrey D.
ORCID: Rothstein, Jeffrey D.
Huang, Yanhua H.
Bergles, Dwight E.
Gupta, Pankaj
Fisher, Paul B.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2005-01
Volume: 433
Issue: 7021
Pages: 73-77
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature03180
OpenAlex: W2083204774
Cited by: 1,518
References: 27
Citations by year: 2026: 49 · 2025: 52 · 2024: 47 · 2023: 48 · 2022: 53 · 2021: 55 · 2020: 60 · 2019: 56 · 2018: 52 · 2017: 76 · 2016: 85 · 2015: 84 · 2014: 107 · 2013: 96 · 2012: 98
FWCI: 31.20
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Muscular Dystrophy Association
Johns Hopkins University
Robert Packard Center for ALS Research, Johns Hopkins University
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
Keywords: beta-lactam antibiotics, ceftriaxone, penicillin, GLT-1, glutamate transporters, neuroprotection, glutamate excitotoxicity, amyotrophic lateral sclerosis, ischemic brain injury, motor neuron degeneration, drug repurposing, transcriptional activation, astrocytes
MeSH terms: Animals, Anti-Bacterial Agents, Ceftriaxone, Cell Count, Cells, Cultured, Central Nervous System, Drug Evaluation, Preclinical, Gene Expression Regulation, Mice, Transgenic, Motor Neurons, Penicillins, Promoter Regions, Genetic, RNA, Messenger, United States, United States Food and Drug Administration, Transcriptional Activation, Genes, Reporter, Neuroprotective Agents, Ischemic Preconditioning, Excitatory Amino Acid Transporter 2, beta-Lactams, Mice, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks